Toshiaki Tokumaru, Tadashi Toyama, Yusuke Nakade, Hisayuki Ogura, Megumi Oshima, Shiori Nakagawa, Motoe Furuichi, Shinji Kitajima, Norihiko Sakai, Miho Shimizu, et al. Design and rationale for an open-label, randomized, controlled pilot trial to evaluate the changes in blood uremic toxins in patients with chronic kidney disease by dietary therapy with sake lees. Clinical and Experimental Nephrology. 2024
Megumi Oshima, Tadashi Toyama, Yusuke Nakade, Daichi Yomogida, Takahiro Yuasa, Keisuke Horikoshi, Taichirou Minami, Hisayuki Ogura, Shiori Nakagawa, Taro Miyagawa, et al. Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study. Clinical therapeutics. 2023
Tadashi Toyama, Miho Shimizu, Taihei Yamaguchi, Hidekazu Kurita, Tetsurou Morita, Megumi Oshima, Shinji Kitajima, Akinori Hara, Norihiko Sakai, Atsushi Hashiba, et al. A comprehensive risk factor analysis using association rules in people with diabetic kidney disease. Scientific reports. 2023. 13. 1. 11690-11690
Yuta Yamamura, Norihiko Sakai, Yasunori Iwata, David Lagares, Akinori Hara, Shinji Kitajima, Tadashi Toyama, Taro Miyagawa, Hisayuki Ogura, Koichi Sato, et al. Myocardin-related transcription factor contributes to renal fibrosis through the regulation of extracellular microenvironment surrounding fibroblasts. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2023. 37. 7. e23005
SokCin Tye, Megumi Oshima, Clare Arnott, Brendon L Neuen, Robert A Fletcher, Bruce Neal, Hiddo J L Heerspink. The importance of targeting multiple risk markers in patients with type 2 diabetes: A post-hoc study from the CANVAS programme. Diabetes, obesity & metabolism. 2023. 25. 6. 1638-1645